The complex functions of microRNA-150 in allergy, autoimmunity and immune tolerance

At present, special efforts are being made to develop the strategies allowing for activation of long-lasting antigen-specific immune tolerance in therapy of allergic and autoimmune diseases. Some of these therapeutic approaches are aimed at modulating cell functions at genetic level by using miRNA-based and miRNA-targeting treatments. Simultaneously, the crucial role of extracellular vesicles as natural miRNA conveyors is highlighted for induction of antigen-specific immune tolerance, especially that they appear to be easily manipulatable for therapeutic applications. Among other immune-related miRNAs, miR-150 is getting special attention as it is differently expressed by immune cells at various stages of their maturation and differentiation. In addition, miR-150 is involved in different signaling cascades orchestrating humoral and cell-mediated mechanisms of both innate and adaptive immune responses. Therefore, miR-150 is considered a master regulator of immunity in mammals. Currently, physiological miR-150-dependent regulatory circuits and causes of their malfunctioning that underlie the pathogenesis of allergic and autoimmune disorders are being unraveled. Thus, present review summarizes the current knowledge of the role of miR-150 in the pathogenesis and complications of these diseases. Furthermore, the involvement of miR-150 in regulation of immune responses to allergens and self-antigens and in induction of antigen-specific immune tolerance is discussed with the special emphasis on the therapeutic potential of this miRNA.

Automated summary

Current efforts are focused on developing strategies to activate long-lasting antigen-specific immune tolerance in allergic and autoimmune diseases through genetic modulation of cell functions using miRNA-based treatments. The role of miR-150 in immune responses is of special interest due to its involvement in signaling cascades orchestrating both innate and adaptive immune mechanisms. MiR-150 is considered a master regulator of immunity in mammals and its potential therapeutic applications are being explored in the pathogenesis and complications of allergic and autoimmune disorders.